ArticleAdvances in therapy2024

A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results.

Yuwu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.